At NEA, we are constantly on the lookout for talented entrepreneurs, and unique applications of innovative technologies. Sometimes we are fortunate…

I remember listening skeptically to a talk at MIT by a young Mitch Kapor describing how he was going to take on VisiCalc with an even better…

NEA will invest more than $1.25B in healthcare companies in the next three years. Here's what you should know. As a global, diversified VC firm…

Drug development has always required a surfeit of intestinal fortitude. It can take hundreds of millions of dollars and a decade or more to bring a…

The current wave of venture investing in cybersecurity took off in 2012, catalyzed by three major IPOs: Proofpoint, Splunk and Palo Alto Networks.…

*This piece was originally published by The Washington Business Journal In 1977, an investor named Richard Kramlich met a young man who wanted to…

This post is dedicated to Harry R. Weller. We worked together in framing it and writing it for over two-and-a-half years. The contents are largely…

It’s been about 12 months since I started at NEA as a Designer-In-Residence. We have about 450 companies in our portfolio and I’ve been fortunate to…

“…it’s a healthy thing now and then to hang a question mark on the things you have long taken for granted.” - B. Russell A few weeks ago, I ran into…